Alessandro Della Chà
Chief Executive Officer bij COSMO PHARMACEUTICALS N.V.
Oorsprong van het eerstegraads netwerk van Alessandro Della Chà
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alessandro Della Chà via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
Westfield Capital Management Co. LP
 Westfield Capital Management Co. LP Investment ManagersFinance Westfield Capital Management Co. LP (Westfield) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1989 and is majority-owned by WMS Management LLC. Westfield provides quality investment management services to institutions and wealthy individuals. | Investment Managers | Analyst-Equity | |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a private company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PRIVATE EQUITY HOLDING AG | Investment Managers | Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| GAM HOLDING AG | Investment Managers | Director/Board Member | |
Bank Julius Bär & Co. AG
 Bank Julius Bär & Co. AG Investment ManagersFinance Bank Julius Bär & Co. AG (BJB) is the private banking subsidiary of Julius Bär Gruppe AG (SWX: BAER) in Switzerland. Headquartered in Zurich, BJB was founded in 1890 and provides personal wealth management advice to private clients and family offices. | Investment Managers | Director of Finance/CFO | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| BARRY CALLEBAUT AG | Food: Specialty/Candy | Director of Finance/CFO | |
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Investment Managers | Portfolio Manager-Equities | |
Pharmajani SpA
 Pharmajani SpA Medical DistributorsDistribution Services Part of Nidda Topco SARL, Pharmajani SpA is an Italian company that distributes pharmaceuticals. The private company is based in Arese, Italy. | Medical Distributors | Sales & Marketing | |
20 Minuten AG
 20 Minuten AG Publishing: NewspapersConsumer Services 20 Minuten AG publishes newspapers and provides online information services. It also provides French-language edition 20 minutes for the French-speaking agglomerations of Geneva and Lausanne. In France, the identically named 20 minutes editions are published by Schibsted and Ouest-France. The company is headquartered in Zurich, Switzerland. | Publishing: Newspapers | Founder | |
| Alma Mater Studiorum - Università di Bologna | College/University | Undergraduate Degree Undergraduate Degree | |
| University College Dublin | College/University | Undergraduate Degree Graduate Degree | |
| ABLYNX | Biotechnology | Corporate Officer/Principal | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Chief Executive Officer | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Sapienza University of Rome | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Zurich | College/University | Graduate Degree | |
| University of Milan | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chairman Director/Board Member | |
| CASSIOPEA S.P.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JULIUS BÄR GRUPPE AG | Financial Conglomerates | Director of Finance/CFO | |
| Cosmo Bioscience SpA | Director/Board Member Chairman | ||
iNNutriGEL AG
 iNNutriGEL AG Pharmaceuticals: OtherHealth Technology iNNutriGEL AG develops food supplements made from premium ingredients to improve and support health. The private company is based in Schlieren, Switzerland. The Swiss company's products include Elemental and Innutri Soft gumsTM. | Pharmaceuticals: Other | Director/Board Member | |
| Cosmo Bioscience, Inc. | Director/Board Member | ||
Nielsen SRL
 Nielsen SRL Miscellaneous Commercial ServicesCommercial Services Part of Elliott International Advisors GP LLC, Nielsen SRL is an Italian company that provides accounting services. The private company is based in Turin, Italy. Nielsen was acquired by Crowe Horwath AS SRL on October 11, 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SWISS RE LTD | Multi-Line Insurance | Director of Finance/CFO | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Stiftung Für Angewandte Krebsforschung | Chairman | ||
Wergen & Partner Vermögensverwaltungs AG
 Wergen & Partner Vermögensverwaltungs AG Financial ConglomeratesFinance Wergen & Partner Vermögensverwaltungs AG provides asset management services to private and institutional clients. The company was founded by Manfred Wergen and is headquartered in Wilen bei Wollerau, Switzerland. | Financial Conglomerates | Chairman | |
iOnctura SA
 iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bank Julius Bär & Co. Ltd. /CH/
 Bank Julius Bär & Co. Ltd. /CH/ Major BanksFinance Part of Julius Bär Gruppe AG, Bank Julius Bär & Co. Ltd. is a banking company based in Zurich, Switzerland. The Swiss company provides banking services. Philipp Rickenbacher has been the CEO of the private company since 2009. | Major Banks | Director of Finance/CFO | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Corbin Therapeutics, Inc.
 Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Corbin Therapeutics, Inc. operates as a biotechnology platform. | Internet Software/Services | Chief Executive Officer | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Edesa Biotech Research, Inc. | Director/Board Member |
Statistieken
Internationaal
| Zwitserland | 17 |
| Verenigde Staten | 15 |
| Italië | 11 |
| Canada | 4 |
| Duitsland | 3 |
Sectoraal
| Health Technology | 18 |
| Finance | 13 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 131 |
| Corporate Officer/Principal | 72 |
| Chairman | 55 |
| Founder | 36 |
| Independent Dir/Board Member | 30 |
Sterkste connecties
| Insiders | |
|---|---|
| David Hale | 54 |
| Friedrich von Bohlen und Halbach | 36 |
| Daniel Burgess | 27 |
| Hans Tanner | 24 |
| Michael Carter | 22 |
| David W Maris | 17 |
| Matthew Strobeck | 15 |
| Maria Grazia Roncarolo | 14 |
| Dieter A. Enkelmann | 13 |
| Sean MacDonald | 11 |
| Alexis Marc Joel Louis de Rosnay | 9 |
| Roberto Camerini | 8 |
| Luigi Moro | 8 |
| Diana Harbort | 8 |
| Eimar Cowhey | 7 |
- Beurs
- Insiders
- Alessandro Della Chà
- Bedrijfsconnecties
